Current Report Filing (8-k)

Date : 06/07/2019 @ 8:13PM
Source : Edgar (US Regulatory)
Stock : Diplomat Pharmacy Inc (DPLO)
Quote : 4.0  0.0 (0.00%) @ 12:00AM
Diplomat Pharmacy share price Chart

Current Report Filing (8-k)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  June 3, 2019

 

Diplomat Pharmacy, Inc.

(Exact Name of Registrant as Specified in its Charter)

 


 

Michigan
(State or Other Jurisdiction of
Incorporation)

 

001-36677
(Commission File Number)

 

38-2063100
(IRS Employer
Identification No.)

 

4100 S. Saginaw St.

Flint, Michigan 48507

(Address of Principal Executive Offices)  (Zip Code)

 

(888) 720-4450

(Registrant’s Telephone Number, Including Area Code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see  General Instruction A.2. below):

 

o                              Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o                              Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o                              Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o                              Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  o

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock, no par value per share

 

DPLO

 

New York Stock Exchange

 

 

 


 

Item 5.07   Submission of Matters to a Vote of Security Holders.

 

At the annual meeting of shareholders of the Company held on June 3, 2019, shareholders elected the two Class II director nominees for three-year terms, ratified the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2019, and approved (on an advisory basis) the Company’s named executive officer compensation.  The annual meeting proposals were described in detail in the Company’s definitive proxy statement filed on April 24, 2019 with the Securities and Exchange Commission.

 

The results of the voting are shown below.

 

Proposal 1 — Election of Directors

 

Class II Nominees

 

Votes For

 

Votes Withheld

 

Broker Non-
Votes

 

Benjamin Wolin

 

60,832,969

 

1,133,204

 

8,063,479

 

Kenneth O. Klepper

 

57,697,816

 

4,268,357

 

8,063,479

 

 

Proposal 2—Ratification of the Appointment of Independent Registered Public Accounting Firm

 

Votes For

 

Votes Against

 

Abstain

 

68,363,348

 

1,587,299

 

79,005

 

 

Proposal 3 — Advisory Vote on Named Executive Officer Compensation

 

Votes For

 

Votes Against

 

Abstain

 

Broker Non-
Votes

 

53,878,998

 

8,036,726

 

50,449

 

8,063,479

 

 

2


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Diplomat Pharmacy, Inc.

 

 

 

 

 

By:

/s/ Brian Griffin

 

 

Brian Griffin

 

 

Chief Executive Officer

 

Date: June 7, 2019

 

3


Diplomat Pharmacy (NYSE:DPLO)
Historical Stock Chart

1 Year : From Feb 2019 to Feb 2020

Click Here for more Diplomat Pharmacy Charts.

Diplomat Pharmacy (NYSE:DPLO)
Intraday Stock Chart

Today : Tuesday 25 February 2020

Click Here for more Diplomat Pharmacy Charts.

Latest DPLO Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20200225 13:22:04